Message from the C-Suite | Future Frontiers in Biomedical Innovation for Healthy Aging
Geneva | November 9, 2022 | Deloitte Consulting
13:20 GMT | 14:20 CET | 8:20am EST
Healthy aging will be spurred by future innovation tackling chronic disease and managing multiple co-morbidities that rise in prevalence with age. Bayer’s Head of Pharmaceuticals will describe some of the most exciting biomedical advancements on the horizon.